Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000680321 | SCV000516202 | benign | not provided | 2016-12-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Genetic Services Laboratory, |
RCV000438762 | SCV000593025 | likely benign | not specified | 2016-04-28 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000438762 | SCV000710978 | benign | not specified | 2012-04-30 | criteria provided, single submitter | clinical testing | Thr186Thr in Exon 04 of ACTG1: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue, is not located within the splice consensus sequence, and has been identified in 1.9% (71/3736) of Afr ican American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS; dbSNP rs142893042). |
Invitae | RCV001078888 | SCV001015745 | benign | Autosomal dominant nonsyndromic hearing loss 20; Baraitser-winter syndrome 2 | 2024-01-26 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000680321 | SCV001142903 | benign | not provided | 2018-11-12 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253420 | SCV002524466 | benign | Baraitser-winter syndrome 2 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253419 | SCV002524467 | benign | Autosomal dominant nonsyndromic hearing loss 20 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004551436 | SCV004724078 | benign | ACTG1-related disorder | 2019-08-28 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |